Precision Cancer Medicine
Top Stories
-
Source:
Columbia Engineering
Researchers have developed a multi-organ chip, a novel platform that captures the biology of organ interactions in the body, enabling a new way to study disease progression and treatments.
-
Expert geneticist Dr. Wendy Chung takes us through the ever-evolving genetics landscape and its revolutionary impact in cancer.
-
Two research teams led by experts in oncology and engineering have won pilot grants from the Herbert Irving Comprehensive Cancer Center and Columbia Engineering.
-
"Precision cancer medicine needs to be envisioned as understanding how cancer works, which goes far beyond individual gene mutations." Read Dr. Bass' Disruptors column for the HICCC.
Latest News
-
By Gordana Vunjak-Novakovic
In our Disruptors column, Gordana Vunjak-Novakovic discusses groundbreaking work between engineers and cancer researchers to accelerate personalized therapeutics and better understand the disease.
-
By Meeri Kim
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
-
Five teams of researchers are awarded pilot grants to conduct innovative basic science, translational, and clinical research across multiple diseases.
-
In a new study by Adam Bass, MD, scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
-
Adam Bass, MD, joins the HICCC as the founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.